News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advitech (AVI.V): A Second Preclinical Study with Positive Results for Wound Healing



2/14/2008 3:26:14 PM

QUEBEC CITY, Feb. 14 /CNW Telbec/ - Advitech Inc. ("Advitech" or the "Company") (TSX Venture Exchange: AVI) announces today that a second preclinical study conducted by Dr Charles Doillon, M.D, PhD from the Oncology and Molecular Endocrinology department of the Centre de Recherche du Centre Hospitalier de l'Université Laval ("CHUL") has provided new indications of the wound healing properties of a milk devired fraction originating from the research work on its XP828L and IM technological platforms.

Read at Canada NewsWire


comments powered by Disqus
Advitech
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES